Pricing of forthcoming therapies for hepatitis C in Europe: beyond cost-effectiveness?
Crossref DOI link: https://doi.org/10.1007/s10198-014-0653-x
Published Online: 2014-11-19
Published Print: 2015-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
van de Vooren, Katelijne
Curto, Alessandro
Garattini, Livio
Text and Data Mining valid from 2014-11-19